LULICONAZOLE
UNII RE91AN4S8G

Substance Identification & Data

This profile provides standardized clinical and technical data for Luliconazole, uniquely identified by the FDA Unique Ingredient Identifier (UNII) RE91AN4S8G.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 187164-19-8 and the RxNorm Concept ID (RxCUI) 1482680. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

RE91AN4S8G

CAS Registry Number

187164-19-8

RxNorm Concept ID

1482680

Detailed Substance Profile

Preferred Name

LULICONAZOLE

Official standardized name for this substance within the FDA UNII nomenclature system.

Molecular Formula

RE91AN4S8G

The specific atomic composition represented as a molecular structure string.

InChIKey

C14H9Cl2N3S2

International Chemical Identifier digital signature for unique molecular identification.

SMILES String

YTAOBBFIOAEMLL-REQDGWNSSA-N

Line notation for describing the chemical structure and connectivity of atoms.

NCI Thesaurus

C81510

National Cancer Institute reference terminology for clinical and research data.

PubChem CID

3003141

Unique identification number in the NCBI database of chemical substances.

INN ID

8161

Sequential identifier assigned via the WHO International Nonproprietary Name program.

USAN ID

XX-47

Identifier assigned by the United States Adopted Names Council.

Substance Type

chemical

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Ingredient Role

n1(/C(=C\2/S[C@@H](CS2)c3ccc(cc3Cl)Cl)/C#N)ccnc1

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Luliconazole. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.